Novo Nordisk has won U.S. approval to market a tablet version of its obesity drug Wegovy, a move Bloomberg says is key to defending the companyβs market share against rival Eli Lilly. The authorization, reported on Dec. 23, 2025, allows Novo Nordisk to offer an oral formulation of the medicine in the U.S. market.
The approval represents a strategic step to broaden patient access and compete more directly with emerging alternatives from Eli Lilly. Wegovy is already established as a treatment for obesity; the tablet launch could affect prescribing patterns and market dynamics in the sector.
Bloomberg is the source of the report; no additional sales forecasts or regulatory conditions were cited in the item. #NovoNordisk #Wegovy #EliLilly #obesity #FiatNews
Czech Prime Minister Andrej BabiΕ‘ announced which trust fund he will transfer the Agrofert holding into, signaling an official move of the conglomerate into a designated fiduciary structure. Further details on the chosen fund were disclosed by the prime minister. #Agrofert #CzechRepublic #FiatNews
European futures traded mostly higher in early deals, with futures showing gains across major indices as markets opened on Dec. 23, 2025. Broader moves were described as predominantly in the green in morning trade. #Europe #futures #FiatNews
Mercedes reached a definitive settlement in the United States over an emissions scandal, formally resolving the case in the U.S. market, according to reports. The agreement concludes ongoing litigation tied to the matter. #Mercedes #FiatNews
Google has acquired a company that operates data centres with integrated energy infrastructure, a move that bolsters its physical cloud footprint and energy management capabilities. The deal was reported on Dec. 23, 2025. #Google #FiatNews
Novo Nordisk won U.S. approval to market an oral (pill) version of its weightβloss drug Wegovy, allowing the company to offer an alternative to the injectable formulation and expand treatment options for obesity patients in the U.S. #NovoNordisk #Wegovy #FiatNews
On Dec. 23, 2025, investor Steve Eisman said markets are no longer driven by the Federal Reserve; instead, he identified the future of artificial intelligence as the key market mover. Eisman argued that the Fed is currently βonly fineβtuningβ interest rates, and in such a phase its policy decisions are largely irrelevant for equity performance.
Eismanβs comment frames central bank action as less decisive for stock returns when rate policy is stable or incremental. By contrast, he pointed to AIβs longβterm growth and disruption potential as the primary focus for investors allocating capital and assessing company prospects.
Eisman is a wellβknown market figure whose views reflect a shift among some investors from macro policy drivers to technology fundamentals and sectoral change when forming market expectations. #SteveEisman #Fed #AI #markets #FiatNews
U.S. equity indexes climbed again on December 22, 2025, pushing back toward fresh highs. The S&P 500 rose 0.5% while the Nasdaq gained 0.4% on the day.
In Europe, Germanyβs DAX edged up 0.1%. The moves left major U.S. benchmarks approaching new record levels as of the close on December 22, 2025.
Market participants will watch whether this momentum persists into yearβend amid scheduled economic releases and corporate reporting. #SPX #NASDAQ #DAX #markets #FiatNews
US trade shift after presidential change: the return of Donald Trump to the White House in 2025 is linked to a flurry of new tariffs that raised import duties to levels not seen since the Great Depression, unsettled markets and sparked talks on trade and investment agreements. #trade #FiatNews
Metals rally continues: gold targets its largest annual gain since 1979, silver trades near $70, and copper is close to $12,000. Factors cited include looser monetary policy, geopolitical tensions and strong central bank buying. #Gold #Copper #FiatNews
